Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00007-0/fulltext?dgcid=hubspot_email_gbdalerts&utm_campaign=gbdalerts&utm_medium=email&_hsenc=p2ANqtz-_KU_qrso7Cz4wYvk3CmcAe7HMsiXby-p-tHRNkpJHKTzw9_YZx9QF8EUB8jfv6cU1ja5Fignh2npQOHLmJnyNhP5d6QA&_hsmi=311643152&utm_content=311597708&utm_source=hs_email Background Global evaluations of the progress towards the WHO End TB Strategy 2020 interim milestones on mortality (35% reduction) and incidence (20% reduction) have not been age specific. We aimed to assess global, regional, and national-level burdens of and trends in tuberculosis and its risk factors across five separate age groups, from 1990 to 2021, and to report on age-specific progress between 2015 and 2020.